PharmaTher Holdings Balance Sheet

Financials in millions CAD. Fiscal year is June - May.

Millions CAD. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Cash & Equivalents	0.79	0.92	2.13	5.92	9.15	2.78
Short-Term Investments	0.07	0.2	0.17	0.33	2.97	3.1
Cash & Short-Term Investments	0.86	1.12	2.3	6.25	12.12	5.88
Cash Growth	-33.32%	-51.16%	-63.22%	-48.41%	106.22%	1413.48%
Other Receivables	0.01	0.02	0.02	0.06	0.03	0.03
Receivables	0.01	0.02	0.02	0.06	0.03	0.03
Prepaid Expenses	-	-	0.02	-	0.01	0.03
Total Current Assets	0.87	1.14	2.34	6.31	12.16	5.94
Property, Plant & Equipment	-	-	-	0	0	0
Long-Term Investments	0.19	0.2	0.25	-	-	-
Total Assets	1.06	1.34	2.59	6.31	12.16	5.94
Accounts Payable	0.52	0.36	0.24	0.88	0.32	0.13
Accrued Expenses	0.01	0.01	0.01	0.01	0.01	0.01
Current Income Taxes Payable	-	-	-	-	-	0.04
Total Current Liabilities	0.53	0.37	0.25	0.89	0.33	0.18
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.19
Total Liabilities	0.53	0.37	0.25	0.89	0.33	0.36
Common Stock	8.95	8.5	8.5	8.44	8.44	2.37
Additional Paid-In Capital	0.46	0.71	0.55	0.65	0.65	0.34
Retained Earnings	-13	-12.35	-10.83	-7.78	-1.37	2.64
Comprehensive Income & Other	4.11	4.11	4.11	4.11	4.11	0.23
Shareholders' Equity	0.53	0.97	2.34	5.42	11.83	5.58
Total Liabilities & Equity	1.06	1.34	2.59	6.31	12.16	5.94
Net Cash (Debt)	0.86	1.12	2.3	6.25	12.12	5.88
Net Cash Growth	-33.32%	-51.16%	-63.22%	-48.41%	106.22%	1413.48%
Net Cash Per Share	0.01	0.01	0.03	0.07	0.15	0.08
Filing Date Shares Outstanding	91.02	91.02	88.52	88.17	88.17	69.73
Total Common Shares Outstanding	91.02	91.02	88.52	88.17	88.17	67.73
Working Capital	0.34	0.77	2.09	5.42	11.83	5.76
Book Value Per Share	0.01	0.01	0.03	0.06	0.13	0.08
Tangible Book Value	0.53	0.97	2.34	5.42	11.83	5.58
Tangible Book Value Per Share	0.01	0.01	0.03	0.06	0.13	0.08